Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
25
OPAD Quote, Financials, Valuation and Earnings
Last price:
$1.41
Seasonality move
:
-15.15%
Day range:
$1.51 - $1.60
52-week range:
$0.91 - $6.35
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.07x
P/B ratio:
1.81x
Volume:
2.6M
Avg. volume:
5.6M
1-year change:
-41.83%
Market cap:
$72.2M
Revenue:
$918.8M
EPS (TTM):
-$1.94
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $2.1B | $4B | $1.3B | $918.8M | |
| Revenue Growth (YoY) | -1.08% | 94.54% | 90.89% | -66.74% | -30.1% | |
| Cost of Revenues | $976.5M | $1.9B | $3.8B | $1.2B | $846.6M | |
| Gross Profit | $87.8M | $207.8M | $182.4M | $70.2M | $72.2M | |
| Gross Profit Margin | 8.25% | 10.04% | 4.62% | 5.34% | 7.86% | |
| R&D Expenses | $7.3M | $10.9M | $12.1M | $7.9M | $4.5M | |
| Selling, General & Admin | $94.3M | $30.3M | $58.7M | $50.1M | $40.6M | |
| Other Inc / (Exp) | $834K | $2.7M | $25.1M | $6.2M | $2.6M | |
| Operating Expenses | $101.5M | $188M | $309.7M | $174.6M | $118.2M | |
| Operating Income | -$13.8M | $19.8M | -$127.3M | -$104.4M | -$46M | |
| Net Interest Expenses | $10M | $15.8M | $46M | $18.9M | $18.7M | |
| EBT. Incl. Unusual Items | -$23M | $6.6M | -$148.3M | -$117.1M | -$62.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $163K | $170K | $359K | $163K | $31K | |
| Net Income to Company | -$23.1M | $6.5M | -$148.6M | -$117.2M | -$62.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$23.1M | $6.5M | -$148.6M | -$117.2M | -$62.2M | |
| Basic EPS (Cont. Ops) | -$6.00 | $0.82 | -$9.09 | -$4.44 | -$2.27 | |
| Diluted EPS (Cont. Ops) | -$6.00 | $0.68 | -$9.09 | -$4.44 | -$2.27 | |
| Weighted Average Basic Share | $3.9M | $7.9M | $16.3M | $26.4M | $27.4M | |
| Weighted Average Diluted Share | $3.9M | $9.5M | $16.3M | $26.4M | $27.4M | |
| EBITDA | -$12.5M | $20.3M | -$126.3M | -$103.7M | -$45.4M | |
| EBIT | -$12.9M | $19.8M | -$127.3M | -$104.4M | -$46M | |
| Revenue (Reported) | $1.1B | $2.1B | $4B | $1.3B | $918.8M | |
| Operating Income (Reported) | -$13.8M | $19.8M | -$127.3M | -$104.4M | -$46M | |
| Operating Income (Adjusted) | -$12.9M | $19.8M | -$127.3M | -$104.4M | -$46M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $540.3M | $821.7M | $234.2M | $208.1M | $132.7M | |
| Revenue Growth (YoY) | 189.91% | 52.09% | -71.5% | -11.17% | -36.23% | |
| Cost of Revenues | $487.2M | $819.6M | $210.3M | $190.9M | $123.3M | |
| Gross Profit | $53.1M | $2.2M | $24M | $17.1M | $9.3M | |
| Gross Profit Margin | 9.83% | 0.26% | 10.24% | 8.24% | 7.04% | |
| R&D Expenses | $2.8M | $2.7M | $2.2M | $947K | $788K | |
| Selling, General & Admin | $8.2M | $14.6M | $14.1M | $8.3M | $15.3M | |
| Other Inc / (Exp) | -$13.2M | $2.6M | $4M | $526K | -- | |
| Operating Expenses | $49.7M | $72.4M | $43.5M | $26.1M | $16.1M | |
| Operating Income | $3.5M | -$70.2M | -$19.5M | -$8.9M | -$6.7M | |
| Net Interest Expenses | $5.5M | $15.9M | $4.4M | $5.1M | $3.6M | |
| EBT. Incl. Unusual Items | -$15.2M | -$83.5M | -$20M | -$13.5M | -$11.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $81K | -$3.5M | $6K | $24K | $380K | |
| Net Income to Company | -$15.3M | -$80M | -$20M | -$13.5M | -$11.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$15.3M | -$80M | -$20M | -$13.5M | -$11.6M | |
| Basic EPS (Cont. Ops) | -$1.98 | -$4.86 | -$0.73 | -$0.49 | -$0.37 | |
| Diluted EPS (Cont. Ops) | -- | -$4.86 | -$0.73 | -$0.49 | -$0.37 | |
| Weighted Average Basic Share | $7.7M | $16.5M | $27.3M | $27.4M | $31.3M | |
| Weighted Average Diluted Share | $7.7M | $16.5M | $27.3M | $27.4M | $31.3M | |
| EBITDA | $3.6M | -$69.7M | -$19.4M | -$8.8M | -$6.5M | |
| EBIT | $3.5M | -$70.2M | -$19.5M | -$8.9M | -$6.7M | |
| Revenue (Reported) | $540.3M | $821.7M | $234.2M | $208.1M | $132.7M | |
| Operating Income (Reported) | $3.5M | -$70.2M | -$19.5M | -$8.9M | -$6.7M | |
| Operating Income (Adjusted) | $3.5M | -$70.2M | -$19.5M | -$8.9M | -$6.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.4B | $4.1B | $1.8B | $985M | $628M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.3B | $3.8B | $1.7B | $906.7M | $583.3M | |
| Gross Profit | $162.8M | $297.6M | $8.6M | $78.3M | $44.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $9.5M | $12.3M | $9.7M | $4.9M | $3.6M | |
| Selling, General & Admin | $23.3M | $57.7M | $54.6M | $39.5M | $67.2M | |
| Other Inc / (Exp) | -$12.9M | $36.5M | $9.5M | $3.2M | -- | |
| Operating Expenses | $145.9M | $311.7M | $211.7M | $121.9M | $84.4M | |
| Operating Income | $16.9M | -$14.1M | -$203.1M | -$43.6M | -$39.7M | |
| Net Interest Expenses | $11.3M | $37M | $28.8M | $19.8M | $14.9M | |
| EBT. Incl. Unusual Items | -$7.3M | -$14.6M | -$222.4M | -$60.2M | -$54.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $333K | $35K | $495K | $85K | $385K | |
| Net Income to Company | -$7.7M | -$14.7M | -$222.9M | -$60.3M | -$54.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$7.7M | -$14.7M | -$222.9M | -$60.3M | -$54.9M | |
| Basic EPS (Cont. Ops) | -$0.06 | -$0.79 | -$11.41 | -$2.20 | -$1.94 | |
| Diluted EPS (Cont. Ops) | -- | -$1.09 | -$11.41 | -$2.20 | -$1.94 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $17.4M | -$13.2M | -$202.2M | -$43M | -$38.9M | |
| EBIT | $16.9M | -$14.1M | -$203.1M | -$43.6M | -$39.7M | |
| Revenue (Reported) | $1.4B | $4.1B | $1.8B | $985M | $628M | |
| Operating Income (Reported) | $16.9M | -$14.1M | -$203.1M | -$43.6M | -$39.7M | |
| Operating Income (Adjusted) | $16.9M | -$14.1M | -$203.1M | -$43.6M | -$39.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $3.3B | $1.1B | $744.5M | $453.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.1B | $3B | $1B | $682.9M | $419.7M | |
| Gross Profit | $137.5M | $227.3M | $53.5M | $61.6M | $34M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $7.7M | $9.1M | $6.7M | $3.7M | $2.8M | |
| Selling, General & Admin | $74.7M | $45.4M | $41.3M | $30.7M | $57.3M | |
| Other Inc / (Exp) | -$12.9M | $20.8M | $5.3M | $2.2M | $612K | |
| Operating Expenses | $121.1M | $244.7M | $146.7M | $94M | $60.1M | |
| Operating Income | $16.4M | -$17.4M | -$93.2M | -$32.4M | -$26.1M | |
| Net Interest Expenses | $9.7M | $30.9M | $13.7M | $14.6M | $10.8M | |
| EBT. Incl. Unusual Items | -$6.2M | -$27.4M | -$101.6M | -$44.7M | -$37.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $170K | $35K | $171K | $93K | $447K | |
| Net Income to Company | -$6.3M | -$27.5M | -$101.8M | -$44.8M | -$37.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$6.3M | -$27.5M | -$101.8M | -$44.8M | -$37.6M | |
| Basic EPS (Cont. Ops) | $0.21 | -$1.59 | -$4.06 | -$1.64 | -$1.31 | |
| Diluted EPS (Cont. Ops) | $0.54 | -$1.82 | -$4.06 | -$1.64 | -$1.31 | |
| Weighted Average Basic Share | $15.6M | $48.9M | $78.2M | $82.2M | $86.6M | |
| Weighted Average Diluted Share | $26.6M | $51.2M | $78.2M | $82.2M | $86.6M | |
| EBITDA | $17.1M | -$16.7M | -$92.6M | -$31.9M | -$25.3M | |
| EBIT | $16.7M | -$17.4M | -$93.2M | -$32.4M | -$26.1M | |
| Revenue (Reported) | $1.2B | $3.3B | $1.1B | $744.5M | $453.7M | |
| Operating Income (Reported) | $16.4M | -$17.4M | -$93.2M | -$32.4M | -$26.1M | |
| Operating Income (Adjusted) | $16.7M | -$17.4M | -$93.2M | -$32.4M | -$26.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $43.9M | $194.4M | $140.3M | $79.9M | $73.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.3M | $6.2M | $2.4M | $9.9M | $3.8M | |
| Inventory | $171.4M | $1.1B | $664.7M | $276.5M | $214.2M | |
| Prepaid Expenses | $2.9M | -- | -- | -- | -- | |
| Other Current Assets | -- | $9.8M | $6.8M | $5.2M | $2.6M | |
| Total Current Assets | $227.3M | $1.3B | $814.2M | $371.6M | $294.2M | |
| Property Plant And Equipment | -- | $5.1M | $5.2M | $7.9M | $17.7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $352K | $5M | $5.7M | $3.6M | $9.7M | |
| Total Assets | $235.9M | $1.4B | $825.1M | $381.6M | $316.2M | |
| Accounts Payable | $2.1M | $6.4M | $4.6M | $4.9M | $1.9M | |
| Accrued Expenses | $11.2M | $33.7M | $26M | $11.6M | $10.8M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $1.3M | $2.3M | $2.3M | $963K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $190.3M | $1.1B | $699M | $276M | $251M | |
| Long-Term Debt | $4.7M | -- | -- | $1.4M | $14.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $379.1M | $1.1B | $703.2M | $279.8M | $268.5M | |
| Common Stock | -- | $24K | $25K | $3K | $3K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -$143.3M | $257.6M | $121.9M | $101.8M | $47.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$143.3M | $257.6M | $121.9M | $101.8M | $47.7M | |
| Total Liabilities and Equity | $235.9M | $1.4B | $825.1M | $381.6M | $316.2M | |
| Cash and Short Terms | $43.9M | $194.4M | $140.3M | $79.9M | $73.6M | |
| Total Debt | $181.7M | -- | -- | $1.4M | $14.2M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $136.7M | $223.7M | $113.4M | $58.4M | $33.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $10M | $9.1M | $3.9M | $5.6M | $7.4M | |
| Inventory | $902.1M | $1.2B | $289.6M | $256.5M | $162.4M | |
| Prepaid Expenses | $10.5M | $9.5M | -- | -- | -- | |
| Other Current Assets | -- | -- | $6.5M | $2.6M | -- | |
| Total Current Assets | $1.1B | $1.4B | $413.3M | $323M | $205.6M | |
| Property Plant And Equipment | $9.6M | $5.3M | $4.7M | $14.3M | $16.9M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $193K | $6M | $4.1M | $10.3M | -- | |
| Total Assets | $1.1B | $1.4B | $422.1M | $338.5M | $223.5M | |
| Accounts Payable | $6.1M | $7.8M | $6.4M | $2.6M | $1.9M | |
| Accrued Expenses | $14.7M | $32.8M | $20.2M | $8.7M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $2.2M | $2.3M | $1.4M | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $785.5M | $1.2B | $304.6M | $263.5M | $155.6M | |
| Long-Term Debt | -- | $4.1M | -- | $10.2M | $28M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $825.2M | $1.2B | $306.9M | $273.8M | $183.6M | |
| Common Stock | $24K | $25K | $3K | $3K | $3K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $243.7M | $241M | $115.2M | $64.7M | $39.9M | |
| Total Liabilities and Equity | $1.1B | $1.4B | $422.1M | $338.5M | $223.5M | |
| Cash and Short Terms | $136.7M | $223.7M | $113.4M | $58.4M | $33.6M | |
| Total Debt | -- | $4.1M | -- | $10.2M | $170.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$23.1M | $6.5M | -$148.6M | -$117.2M | -$62.2M | |
| Depreciation & Amoritzation | $434K | $523K | $1M | $728K | $611K | |
| Stock-Based Compensation | $1.4M | $3.1M | $8.3M | $7.9M | $8.1M | |
| Change in Accounts Receivable | $937K | -$3.8M | $3.8M | -$7.6M | $6.1M | |
| Change in Inventories | $169.1M | -$949.6M | $374.1M | $379.3M | $57.9M | |
| Cash From Operations | $154.9M | -$921.9M | $305.4M | $261.6M | $20.8M | |
| Capital Expenditures | $2.9M | $13.7M | $1.1M | $127K | $5.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$2.9M | -$11.7M | -$1.1M | $2M | -$5.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $800M | $2.8B | $3.2B | $900.8M | $807.9M | |
| Long-Term Debt Repaid | -$960.5M | -$1.9B | -$3.5B | -$1.3B | -$829.5M | |
| Repurchase of Common Stock | -- | $51.2M | -- | -- | -- | |
| Other Financing Activities | -$457K | $225.1M | -$931K | -$2M | -$313K | |
| Cash From Financing | -$131.1M | $1.1B | -$358.5M | -$324M | -$21.8M | |
| Beginning Cash (CF) | $29.9M | $194.4M | $140.3M | $79.9M | $73.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $20.9M | $143.7M | -$54.1M | -$60.4M | -$6.3M | |
| Ending Cash (CF) | $50.7M | $338.1M | $86.2M | $19.6M | $67.3M | |
| Levered Free Cash Flow | $152M | -$935.6M | $304.3M | $261.5M | $15.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$15.3M | -$80M | -$20M | -$13.5M | -$11.6M | |
| Depreciation & Amoritzation | $156K | $515K | $176K | $150K | $253K | |
| Stock-Based Compensation | $1.1M | $2.3M | $2M | $715K | $815K | |
| Change in Accounts Receivable | -$2.9M | $3.8M | -$2.4M | $1.2M | $155K | |
| Change in Inventories | -$410.1M | $77.9M | -$79.4M | $50.4M | $48.4M | |
| Cash From Operations | -$407.3M | $20.6M | -$94.5M | $39.6M | $40M | |
| Capital Expenditures | $7.7M | $192K | -- | $883K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$7.7M | -$192K | $2.3M | -$881K | $19K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $813.7M | $757.6M | $279.2M | $132.2M | -- | |
| Long-Term Debt Repaid | -$549.7M | -$753.9M | -$195.7M | -$185.3M | -- | |
| Repurchase of Common Stock | $51.2M | -- | -- | -- | -- | |
| Other Financing Activities | $229.7M | -$481K | -$118K | -$106K | -- | |
| Cash From Financing | $493.7M | $3.4M | $83.4M | -$53.3M | -$33.1M | |
| Beginning Cash (CF) | $136.7M | $223.7M | $113.4M | $58.4M | $33.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $78.8M | $23.7M | -$8.8M | -$14.6M | $6.9M | |
| Ending Cash (CF) | $215.4M | $247.4M | $104.6M | $43.9M | $40.5M | |
| Levered Free Cash Flow | -$414.9M | $20.4M | -$94.5M | $38.7M | $40M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$7.7M | -$14.7M | -$222.9M | -$60.3M | -$54.9M | |
| Depreciation & Amoritzation | $559K | $854K | $814K | $636K | $859K | |
| Stock-Based Compensation | $2.8M | $7.1M | $7.9M | $9.8M | $4.1M | |
| Change in Accounts Receivable | -$5.3M | $916K | $5.2M | -$1.7M | -$1.8M | |
| Change in Inventories | -$767M | -$328.8M | $842M | $30.5M | $86.8M | |
| Cash From Operations | -$745.8M | -$309M | $674.3M | -$27.7M | $49.5M | |
| Capital Expenditures | $16.4M | $995K | $243K | $1.3M | $5.2M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$14.4M | -$995K | $169K | $464K | -$5.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $4B | $997.9M | $819.2M | -- | |
| Long-Term Debt Repaid | -- | -$3.6B | -$1.9B | -$845.1M | -- | |
| Repurchase of Common Stock | $51.2M | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$5.2M | -$522K | -$1.8M | -- | |
| Cash From Financing | $857.3M | $397M | -$784.7M | -$27.7M | -$69.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $97.2M | $87M | -$110.3M | -$55M | -$24.8M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$762.2M | -$310M | $674M | -$29M | $44.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$6.3M | -$27.5M | -$101.8M | -$44.8M | -$37.6M | |
| Depreciation & Amoritzation | $433K | $764K | $556K | $464K | $712K | |
| Stock-Based Compensation | $2.3M | $6.3M | $5.9M | $7.8M | $3.9M | |
| Change in Accounts Receivable | -$7.7M | -$3M | -$1.5M | $4.3M | -$3.5M | |
| Change in Inventories | -$722M | -$101.2M | $366.7M | $18M | $47M | |
| Cash From Operations | -$704.8M | -$91.9M | $277M | -$12.4M | $16.3M | |
| Capital Expenditures | $13.6M | $917K | $90K | $1.2M | $1.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$11.6M | -$917K | $322K | -$1.2M | -$1.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.7B | $2.9B | $709.7M | $628.1M | $310.9M | |
| Long-Term Debt Repaid | -$1.1B | -$2.8B | -$1.1B | -$635.9M | -$332.9M | |
| Repurchase of Common Stock | $51.2M | -- | -- | -- | -- | |
| Other Financing Activities | $229.5M | -$751K | -$342K | -$150K | -$197K | |
| Cash From Financing | $802.3M | $122.1M | -$304.2M | -$7.9M | -$55.2M | |
| Beginning Cash (CF) | $216.5M | $659.4M | $378.6M | $210M | $96.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $85.9M | $29.2M | -$26.9M | -$21.5M | -$40M | |
| Ending Cash (CF) | $302.4M | $688.6M | $351.7M | $188.4M | $56.1M | |
| Levered Free Cash Flow | -$718.4M | -$92.8M | $276.9M | -$13.6M | $15.2M | |
Get OPAD Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
OPAD
Sector
P/E ratio
--
17.58x
PEG ratio
--
0.05x
P/B ratio
1.81x
0.82x
Price / LTM sales
0.07x
3.20x
Growth Metrics
OPAD
Sector
Revenue growth
-36.23%
3.09%
Earnings growth
24.81%
4.98%
Revenue (5-year growth)
-3.11%
2.86%
Earnings forecast
-$0.27
$0.14
Profitability
OPAD
Sector
Profitability FY 2024
$72.2M
$153.7M
Return on invested capital
-20.27%
2.03%
Return on assets
-19.32%
1.81%
Return on equity
-130.09%
3.5%
Earnings Date
Last Earnings Date
Nov
3
Next Earnings Date
Feb
23
Estimated Next Earnings Date
Feb
2
Balance Sheet
OPAD
Sector
Total cash
$33.6M
$73.7M
Short term investments
--
$11.9M
Total assets
$316.2M
$3.2B
Long term debt
$170.2M
$349.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
67
Is GOOG Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Buy
53
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Alerts
Buy
80
BNR alert for Jan 15
Burning Rock Biotech Ltd. [BNR] is up 15.71% over the past day.
Sell
37
TCOM alert for Jan 15
Trip.com Group Ltd. [TCOM] is down 2.47% over the past day.
Sell
39
DAVE alert for Jan 15
Dave, Inc. [DAVE] is up 3.53% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
